Athersys stroke treatment fails study, shares slide

April 17, 2015 10:41 AM

13 0

(Reuters) - Drug developer Athersys Inc said its cell therapy failed in a mid-stage study testing it as a treatment for a type of stroke, sending its shares down more than 50 percent in premarket trading.

Data showed that the therapy did not meet the primary and secondary endpoints of the study.

Read more

To category page